Zhang YJ - Search Results

1

Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection.

Xu HX, Chen T, Wang WQ, Wu CT, Liu C, Long J, Xu J, Zhang YJ, Chen RH, Liu L, Yu XJ. Xu HX, et al. Among authors: zhang yj. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1093-102. doi: 10.1007/s00259-014-2688-8. Epub 2014 Feb 13. Eur J Nucl Med Mol Imaging. 2014. PMID: 24522797

2

Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation.

Hu SL, Yang ZY, Zhou ZR, Yu XJ, Ping B, Zhang YJ. Hu SL, et al. Among authors: zhang yj. Nucl Med Commun. 2013 Jun;34(6):533-9. doi: 10.1097/MNM.0b013e328360668a. Nucl Med Commun. 2013. PMID: 23503000

3

Clinical application of ^99mTc-HYNIC-TOC SPECT/CT in diagnosing and monitoring of pancreatic neuroendocrine neoplasms.

Xu J, Li Y, Xu X, Zhang J, Zhang Y, Yu X, Huang D. Xu J, et al. Ann Nucl Med. 2018 Aug;32(7):446-452. doi: 10.1007/s12149-018-1266-8. Epub 2018 Jun 20. Ann Nucl Med. 2018. PMID: 29926342

4

Machine learning based on clinico-biological features integrated ¹⁸F-FDG PET/CT radiomics for distinguishing squamous cell carcinoma from adenocarcinoma of lung.

Ren C, Zhang J, Qi M, Zhang J, Zhang Y, Song S, Sun Y, Cheng J. Ren C, et al. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1538-1549. doi: 10.1007/s00259-020-05065-6. Epub 2020 Oct 15. Eur J Nucl Med Mol Imaging. 2021. PMID: 33057772 Free PMC article.

5

Clinical value of [(18)F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer.

Jiang J, Yang Z, Zhang Y, Xu X, Wang M, Hu S, Yao Z, Pan H, Zhang Y, Li D. Jiang J, et al. Clin Imaging. 2014 Nov-Dec;38(6):797-801. doi: 10.1016/j.clinimag.2014.05.007. Epub 2014 May 21. Clin Imaging. 2014. PMID: 24973077 Clinical Trial.

6

Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases.

Hu SL, Zhou ZR, Zhang YJ. Hu SL, et al. Among authors: zhang yj. Abdom Imaging. 2012 Aug;37(4):675-9. doi: 10.1007/s00261-011-9800-3. Abdom Imaging. 2012. PMID: 21898082

7

Potential values of metabolic tumor volume and heterogeneity measured with ¹⁸F-FDG PET/CT pretreatment to evaluate local control for esophageal squamous cell carcinoma treated with nonsurgical therapy.

Liu Q, Fu XL, Yu W, Zhu ZF, Zhang YJ. Liu Q, et al. Among authors: zhang yj. Nucl Med Commun. 2015 May;36(5):423-9. doi: 10.1097/MNM.0000000000000267. Nucl Med Commun. 2015. PMID: 25603275

8

18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.

Zhou M, Wang C, Hu S, Zhang Y, Yao Z, Li J, Guo W, Zhang Y. Zhou M, et al. Nucl Med Commun. 2013 Jul;34(7):694-700. doi: 10.1097/MNM.0b013e328361663a. Nucl Med Commun. 2013. PMID: 23604223

9

Is 18F-FDG PET/CT more reliable than 99mTc-MDP planar bone scintigraphy in detecting bone metastasis in nasopharyngeal carcinoma?

Yang Z, Zhang Y, Shi W, Zhu B, Hu S, Yao Z, Pan H, Hu C, Zhang Y, Li D. Yang Z, et al. Ann Nucl Med. 2014 Jun;28(5):411-6. doi: 10.1007/s12149-014-0831-z. Epub 2014 Mar 8. Ann Nucl Med. 2014. PMID: 24610681

10

Textural features of ¹⁸F-FDG PET after two cycles of neoadjuvant chemotherapy can predict pCR in patients with locally advanced breast cancer.

Cheng L, Zhang J, Wang Y, Xu X, Zhang Y, Zhang Y, Liu G, Cheng J. Cheng L, et al. Ann Nucl Med. 2017 Aug;31(7):544-552. doi: 10.1007/s12149-017-1184-1. Epub 2017 Jun 23. Ann Nucl Med. 2017. PMID: 28646331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,708 results

Search Page

Filters